Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate
- 1 October 2005
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 182 (2) , 331-340
- https://doi.org/10.1016/j.atherosclerosis.2005.02.016
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003
- Intronic mutations outside of Alu -repeat-rich domains of the LDL receptor gene are a cause of familial hypercholesterolemiaHuman Genetics, 2002
- Rigorous detection and vigorous treatment of familial hypercholesterolaemiaThe Lancet, 2001
- Outcome of case finding among relatives of patients with known heterozygous familialBMJ, 2000
- I705 variant in the low density lipoprotein receptor gene has no effect on plasma cholesterol levelsJournal of Medical Genetics, 2000
- A New Locus for Autosomal Recessive Hypercholesterolemia Maps to Human Chromosome 15q25-q26American Journal of Human Genetics, 2000
- Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemiaJournal of Clinical Investigation, 1999
- Comparison of the Genetic Defect with LDL-Receptor Activity in Cultured Cells from Patients With a Clinical Diagnosis of Heterozygous Familial HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- A novel single base deletion in the LDLR gene (211delG): Effect on serum lipid profiles and the influence of other genetic polymorphisms in the ACE, APOE and APOB genesAtherosclerosis, 1996
- A point mutation in the low density lipoprotein receptor gene that causes exon skipping and is associated with severe familial hypercholesterolemia (FH)Atherosclerosis, 1994